• Oxaliplatin in Translational Oncology: Mechanistic Insigh...

  2025-10-04

  This thought-leadership article elucidates the molecular mechanisms of Oxaliplatin—a third-generation platinum-based chemotherapeutic agent—and its strategic integration into advanced preclinical and translational research models. By synthesizing breakthrough findings on DNA adduct formation, apoptosis induction, and mechanisms of resistance, we provide actionable guidance for researchers aiming to bridge the gap between bench and bedside. With a focus on leveraging patient-derived assembloids and overcoming chemoresistance, this piece advances the dialogue beyond conventional product descriptions, positioning Oxaliplatin at the forefront of precision oncology.

• Phosphatase Inhibitor Cocktail 100X: Ensuring Unbiased Ph...

  2025-10-03

  Discover how the Phosphatase Inhibitor Cocktail 100X enables uncompromised protein phosphorylation preservation across advanced applications. This article uniquely explores the molecular interplay of phosphatase inhibition and chromatin biology, revealing new insights for precision immunoblotting and mass spectrometry.

• H 89 2HCl: Potent PKA Inhibitor for cAMP Pathway Dissection

  2025-10-02

  H 89 2HCl stands out as a potent and selective PKA inhibitor, empowering researchers to precisely interrogate cAMP-dependent signaling in bone, neurodegenerative, and cancer models. Its robust selectivity profile and proven efficacy in complex cellular contexts make it a premier tool for dissecting protein phosphorylation events and advancing translational research.

• 7-Ethyl-10-hydroxycamptothecin: Molecular Mechanisms and ...

  2025-10-01

  Explore the multifaceted actions of 7-Ethyl-10-hydroxycamptothecin, a potent DNA topoisomerase I inhibitor, as both a cell cycle arrest inducer and apoptosis inducer in colon cancer cells. Uncover new mechanistic insights and research applications that set this article apart from standard reviews.

• Monomethyl Auristatin E: ADC Payloads for Precision Cance...

  2025-09-30

  Monomethyl auristatin E (MMAE) is revolutionizing targeted cancer therapy as a potent antimitotic agent for antibody-drug conjugates (ADCs). This article breaks down experimental workflows, advanced use-cases, and troubleshooting strategies to maximize the impact of MMAE in cancer research and drug development.

• Bortezomib (PS-341): Decoding Proteasome Inhibition in Py...

  2025-09-29

  Explore how Bortezomib (PS-341), a reversible proteasome inhibitor, uniquely advances our understanding of 20S proteasome inhibition and its impact on pyrimidine salvage pathway regulation in cancer therapy research. This article provides an in-depth, mechanistic analysis distinct from prior content and integrates the latest findings on mTORC1-mediated metabolic control.

• Cy3 TSA Fluorescence System Kit: Redefining Spatial Quant...

  2025-09-28

  Explore how the Cy3 TSA Fluorescence System Kit revolutionizes signal amplification in immunohistochemistry by enabling quantitative, spatially resolved detection of low-abundance biomolecules within complex tumor microenvironments. Discover advanced strategies for multiplex fluorescence microscopy and the integration of TSA with emerging cancer metabolism research.

• Metronidazole: Advanced Insights into OAT3 Inhibition and...

  2025-09-27

  Explore the multifaceted role of Metronidazole as a nitroimidazole antibiotic and potent OAT3 inhibitor. This article provides a unique scientific perspective on drug-drug interaction modulation and advanced applications in anaerobic bacteria targeting and protozoa treatment research.

• Clozapine N-oxide (CNO): Transforming Chemogenetic Dissec...

  2025-09-26

  Discover how Clozapine N-oxide (CNO) revolutionizes neuroscience research as a selective chemogenetic actuator. This article uniquely explores its application in modulating retino-amygdala circuits and anxiety mechanisms, offering advanced insights for GPCR signaling and neuronal activity studies.

• Canagliflozin Hemihydrate: Unraveling SGLT2 Inhibition in...

  2025-09-25

  Explore the unique role of Canagliflozin hemihydrate as a small molecule SGLT2 inhibitor in dissecting glucose homeostasis pathways and metabolic disorder mechanisms. This article provides a systems biology perspective that extends beyond traditional diabetes research.

• Anti Reverse Cap Analog (ARCA): Unlocking Precision mRNA ...

  2025-09-24

  Discover how Anti Reverse Cap Analog (ARCA), 3´-O-Me-m7G(5')ppp(5')G, empowers researchers with precision mRNA capping for enhanced translation and metabolic regulation. This article uniquely connects ARCA's biochemical mechanism to mitochondrial enzyme control, illuminating new frontiers in synthetic mRNA therapeutics.

• Bufuralol Hydrochloride in Human Intestinal Organoid Models

  2025-09-23

  Explore the applications of Bufuralol hydrochloride as a non-selective β-adrenergic receptor antagonist in advanced human organoid systems for cardiovascular pharmacology research. This article provides rigorous scientific context for β-adrenergic modulation studies using cutting-edge in vitro models.

• First investigation of numerous membered ether linked macroc

  2025-03-03

  

  First, investigation of numerous 12-14-membered ether-linked macrocycles revealed that smaller motifs were most lipophilic efficient. Compound (3) (12-membered macrocycle) exhibited good cellular potencies (ALK IC50 = 1.0 nM; ALK-L1196 M IC50 = 20 nM) and the highest LipE (4.4) with picomolar bindin

• The functional observations from the

  2025-03-03

  

  The functional observations from the present study are based on neoplastic parp inhibitors (HSY), and comparative expressions between normal salivary and pleomorphic adenoma tissues. However, there is a paucity of information on AhR expression and function in normal salivary gland, not neoplastic,

• Role of APPL in endosomal signaling

  2025-03-03

  

  Role of APPL in endosomal signaling pathways Endosomes consist of distinct membrane subdomains within individual organelles and assist in the translation of extracellular stimuli via cytoplasmic transduction cascades to the nucleus [3], [74]. Endosomal abnormalities are associated with the pathogen

16363 records 6/1091 page Previous Next First page 上5页 678910 下5页 Last page